Meta AnalysisID 6941
南非醉茄治疗精神疾病：一项系统评价
CRD42023467959
What are the effects of ashwagandha on mental illness?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6941
- Evidence Id
- 15499
- Core Evidence Id
- 15499
- Source Meta Analysis Id
- 6924
- Herb2 Meta Analysis Id
- HBMA006924
- Crd Id
- CRD42023467959
- Title
- Ashwagandha for mental illness: a systematic review
- Review Question
- What are the effects of ashwagandha on mental illness?
- Study Type Included
- Published and unpublished randomized controlled trials (RCTs) or cross-over trials. Without other restrictions.
- Condition Being Studied
- Any mental disorders, including schizophrenia and psychotic spectrum disorders, bipolar disorder, depressive disorder, anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder.
- Participant
- People of any age (i.e., both adults and children) suffering from any mental disorder. These disorders have to be defined according to standard operational diagnostic criteria (DSM or ICD, possibly updated to their latest versions).
- Animal
- Human Disease Modelled
- Intervention
- Withania, also known as "Withania Somnifera" or "Ashwagandha", is a perennial herbaceous plant, belonging to the "Solanaceae". The plant's active constituents are reported to have an antioxidant activity which may contribute at least in part to the antistress, immunomodulatory, cognition facilitating, anxiolytic, and anti-inflammatory properties. Ashwagandha is generally administered orally.
- Comparator Control
- Placebo or treatment as usual. When multiple comparators are provided, we prefer to consider as controls the Placebo group.
- Main Outcome
- The primary outcome will be the difference in pre-post treatment changes in the level of psychiatry disease's symptoms, measured with any validated tool.
- Outcome Measure
- Additional Outcome
- Pre-post treatment changes in cognition and sleep.
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Mattia Marchi [email protected]
- Organisational Affiliation
- University of Modena and Reggio Emilia
- Funding Source
- This review is not funded.
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Italy
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-09-28
- Registration Date
- 2023-10-09
- Anticipated Start Date
- 2023-05-01
- Anticipated Completion Date
- 2024-02-01
- Title Cn
- 南非醉茄治疗精神疾病：一项系统评价
- Title En
- Ashwagandha for mental illness: a systematic review
- Bilingual Status
- complete